Z-drugs are associated with cardiovascular outcomes among patients with heart failure: a population-based cohort study in Hong Kong.
Our findings suggest that the use of Z-drugs increases the risks of adverse cardiovascular outcomes among patients with HF.
Authors
- Anping Cai (ORCID: https://orcid.org/0000-0003-3953-5881)
- Q W Ren (ORCID: https://orcid.org/0000-0003-0712-9299)
- Jingnan Zhang (ORCID: https://orcid.org/0000-0002-4865-5212)
- Haiyue Yang
- Xinli Li (ORCID: https://orcid.org/0000-0002-7889-6359)
- Ran Guo (ORCID: https://orcid.org/0000-0002-9424-8140)
- Jiayi Huang (ORCID: https://orcid.org/0000-0002-5153-506X)
- Renqiang Yang (ORCID: https://orcid.org/0000-0001-6517-8860)
- Wenli Gu (ORCID: https://orcid.org/0000-0002-9964-8805)
- Kai‐Hang Yiu
Institutions
- Nanchang University (CN)
- Guangdong General Hospital (CN)
- Second Affiliated Hospital of Nanchang University (CN)
- Guangdong Academy of Medical Sciences (CN)
- Jiangsu Province Hospital (CN)
- Nanjing Medical University (CN)
Publication Details
- Journal
- PubMed
- Published
- 2025-03-26
- DOI
- https://doi.org/10.1093/eurjpc/zwaf128
- Citations
- 2
- Primary Topic
- Receptor Mechanisms and Signaling
- Type
- article
- Field-Weighted Citation Impact
- 1.61